Kura Oncology reports lymphoma success with cancer drug

San Diego Biotechnology Network
San Diego Biotechnology Network
Kura Oncology reports lymphoma success with cancer drug
Loading
/

San Diego biotech said its drug, tipifarnib, produced positive results in a Phase 2 trial for a form of lymphoma.


ADVERTISEMENT — Advertise With Biotech Networks